Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

69 results
  1. ... designed to test the hypothesis that NSAIDs, either selective (celecoxib) or nonselective (naproxen) cyclooxygenase-2 inhibitors, would work for the primary prevention of CATD. 255 – 258 The trial had three ...
  2. ... Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006 Apr;101(4):701– ...
  3. ... Thai. 2009] Gastrointestinal and cardiovascular risk of non-selective NSAIDs and ... for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic ...
  4. ... from the market after a long-term polyp prevention trial found an increased risk of myocardial infarction compared with placebo. 20 On December 9, 2004, the FDA issued a black-box warning for the selective COX-2 inhibitor valdecoxib for life-threatening skin reactions and increased ...
  5. ... thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib. ... an international consensus statement. Lancet Oncol. 2009; 10 ( ...
  6. ... randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women. ... inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal ...
  7. ... the overall pooled estimate for all COX-2 selective NSAIDs, and just met ... by specific COX-2 inhibitor, nor were estimates of CV risk with specific ...
  8. ... and inpatient hospitalizations), and comedication with nonopioid agents (selective ... NSAIDs: nonsteroidal antiinflammatory drugs; PTSD=post-traumatic stress ...
  9. ... G, et al.: Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for ... J, et al.: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal ...
  10. ... explicitly referred to K.6. Non-specialist management – selective COX-2 inhibitors View in own window Reference Reason for exclusion ... 33-37 All participants had already tolerated a selective COX-2 inhibitor Di Leo E, Aloia AM, Nettis E, Cardinale ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · next · last